Cara Therapeutics CEO Derek Chalmers' 2021 pay jumps 250% to $10M
Cara Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 22, 2022
Cara Therapeutics reported fiscal year 2021 executive compensation information on April 22, 2022.
In 2021, six executives at Cara Therapeutics received on average a compensation package of $4.3M, a 157% increase compared to previous year.
Average pay of disclosed executives at Cara Therapeutics
Derek Chalmers, Chief Executive Officer, received $10M in total, which increased by 250% compared to 2020. 78% of Chalmers' compensation, or $8M, was in option awards. Chalmers also received $570K in salary, $1.7M in stock awards, as well as $11K in other compensation.
For fiscal year 2021, the median employee pay was $192,240 at Cara Therapeutics. Therefore, the ratio of Derek Chalmers' pay to the median employee pay was 53 to one.
Christopher Posner, Chief Executive Officer, received a compensation package of $9.9M. 70% of the compensation package, or $6.9M, was in option awards.
Frédérique Menzaghi, Chief Scientific Officer, earned $1.7M in 2021, a 25% increase compared to previous year.
Joana Goncalves, Chief Medical Officer, received $1.7M in 2021, which increases by 30% compared to 2020.
Scott Terrillion, General Counsel, earned $1.6M in 2021, a 33% increase compared to previous year.
Thomas Reilly, Chief Financial Officer, received $810K in 2021, which decreases by 49% compared to 2020.
Related executives
Christopher Posner
Cara Therapeutics
Chief Executive Officer
Derek Chalmers
Cara Therapeutics
Chief Executive Officer
Thomas Reilly
Cara Therapeutics
Chief Financial Officer
Frédérique Menzaghi
Cara Therapeutics
Chief Scientific Officer
Joana Goncalves
Cara Therapeutics
Chief Medical Officer
Scott Terrillion
Cara Therapeutics
General Counsel
You may also like
Source: SEC filing on April 22, 2022.